Evaxion A (EVAX) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about EVAX filings

Are insiders buying or selling Evaxion Biotech AS (EVAX) stock?

Neither. Evaxion Biotech AS (EVAX) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded EVAX recently?

None. No member of Congress disclosed a EVAX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EVAX smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

2 funds hold a position.

Questions about EVAX filings

Are insiders buying or selling Evaxion Biotech AS (EVAX) stock?

Neither. Evaxion Biotech AS (EVAX) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded EVAX recently?

None. No member of Congress disclosed a EVAX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EVAX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Earnings came in $0.49 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.50-$0.49 miss

-$0.01 expected

Revenue

$0.00

SEC filing

Next report

Estimated report: Nov 19, 2026, in 5 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	-$0.50est. -$0.01	-$0.49miss	$0.00SEC filing	-100.0%from $37.0K
Mar 31, 2026Reported May 7, 2026	-$0.01est. -$0.01	+$0.00in line	Not on file	Not on file
Dec 31, 2025Reported Mar 5, 2026	-$0.01est. -$0.01	+$0.00in line	$7.5M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	$0.01est. -$0.01	+$0.02beat	Not on file	Not on file
Jun 30, 2025Reported Aug 14, 2025	-$1.00est. -$0.58	-72.41%miss	$37.0KSEC filing	-76.0%from $154.0K
Mar 31, 2025Reported May 27, 2025	-$0.50est. -$0.70	+28.57%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 26, 2025	-$0.07est. -$0.15	+53.33%beat	$3.3M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Oct 31, 2024	-$0.20est. -$0.60	+66.67%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $2.85
High: $2.88
Low: $2.75
Prev close: $2.91
52-wk high: $6.92
52-wk low: $2.67
Mkt cap: $26.8M
ROE: -109.9%
Fwd P/E: 3.6x
Beta: 0.56
P/S: 3.6x
P/B: 2.8x
Profit margin: -115.5%
Op margin: -116.0%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -115.5%
Forward P/E: 3.57
Market cap: $27M

Valuation

P/S3.58
P/B2.77

Quality

Operating margin-116.0%
ROE-109.9%
ROA-26.0%

Growth

Beta0.56

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

26oversold

20D volatility

136%annualized

52-week range

$2.77

$2.67$6.92

20D support

$2.67recent floor

20D resistance

$4.50recent ceiling

Returns

5D +0.4%20D -1.1%60D -12.1%

Price vs moving averages

SMA20 -11.4%SMA50 -11.5%SMA200 -19.5%

Volume pace

3.15xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 13, 2026

-$0.50est. -$0.01

-$0.49

$0.00SEC filing

-100.0%from $37.0K

Mar 31, 2026May 7, 2026

-$0.01est. -$0.01

+$0.00

Not on file

Dec 31, 2025Mar 5, 2026

-$0.01est. -$0.01

+$0.00

$7.5M · FYSEC filing

No year-ago quarter

Sep 30, 2025Nov 6, 2025

$0.01est. -$0.01

+$0.02

Not on file

Jun 30, 2025Aug 14, 2025

-$1.00est. -$0.58

-72.41%

$37.0KSEC filing

-76.0%from $154.0K

Mar 31, 2025May 27, 2025

-$0.50est. -$0.70

+28.57%

Not on file

Dec 31, 2024Mar 26, 2025

-$0.07est. -$0.15

+53.33%

$3.3M · FYSEC filing

No year-ago quarter

Sep 30, 2024Oct 31, 2024

-$0.20est. -$0.60

+66.67%

Not on file

Evaxion Biotech AS

Smart money at a glance

What do analysts expect?

Questions about EVAX filings

Questions about EVAX filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.49 a share below what analysts expected.

Estimated report: Nov 19, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Evaxion Biotech AS

Smart money at a glance

What do analysts expect?

Questions about EVAX filings

Questions about EVAX filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.49 a share below what analysts expected.

Estimated report: Nov 19, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Evaxion Biotech AS

Overview

Questions about EVAX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Evaxion Biotech AS

Overview

Questions about EVAX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.